Specialty Pharmacy

Organ rejection is caused by donor dendritic cells being rapidly replaced by the recipient’s cells.

Hepatitis C testing is often skipped during baby boomer physician office visits.

Top news of the week in oncology, and cancer drug development.

Combination therapy may be viable for patients with moderate-to-severe psoriasis unresponsive to non-biologic treatments.

Breast cancer patients who expected significant side effects from adjuvant hormone therapy reported worse adverse events.

The impact of antiviral hepatitis C drugs in day-to-day life will be examined.

Newly found protein sheds light on insulin resistance and type 2 diabetes.

Researchers advance understanding of how breast cancer drugs work inside human cells.

Findings point to need to target only non-damaged HIV in the body.

Top news of the day from across the health care landscape.

Microfluidic device may improve treatment of abnormal blood coagulation.

Adding and analyzing data points at each step of the treatment process in specialty pharmacy can enhance patient care.

Patients administered PRO 140 monotherapy reach 2 years of complete remission in trial.

Obesity management in women is vital to reduce the risk of cancer.

Gene therapy may protect against rare neurodegenerative disorder.

Hormone receptor testing may be unnecessary in breast cancer patients.

US National Institutes of Health grant will link universities studying Alzheimer’s disease and related dementia.

Stem cell medical tourism increasingly takes advantage of patients with debilitating conditions.

Top news of the day from across the healthcare landscape.

Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.

The Specialty Pharmacy Podcast Show will cover the vast business topics about the complex business of the specialty pharmacy sector of the pharmacy industry.

Pharmacists prefer a distinct name for biosimilars with a nonproprietary name and a designated suffix.

Patients with septic perianal Crohn’s disease have infected abscesses that are difficult to treat.

Study targets how HIV avoids immune system defenses.

Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.

Top news of the day from across the health care landscape.

Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers carry similar outcomes in study.

Aromatase inhibitors in human estrogen-receptor positive breast cancer can cause tumor mutations.